![]() |
![]() | ![]() |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
I have followed ID Biomedical from it's original IPO as they have pursued a number of massive market products. A while back, they signed a licensing deal with vaccine company Pasteur Merieux Connaught for a Tuberculosis vaccine. Other products include a rapid DNA test called Cycling Probe Technology which is similar to the Hoffman LaRoche test PCR, along with a test for staphylococcus (sp?). Like all biotechs they are currently at the low end of their trading range and look like a good potential buy to me. The shares trade on Toronto (IDB) and Nasdaq (IDBEF). Any biotech types out there with some comments?? Thanks. Regards, Kaiser...
| ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |